多巴胺和皮层神经元具有不同的帕金森突变显示 lysosomal 和线粒体功能障碍的变化
Jessica Chedid1,2, Yan Li2,3,4, Adahir Labrador-Garrido1,2
1The University of Sydney, Brain and Mind Centre & Faculty of Medicine and Health School of Medical Sciences, Sydney, NSW, Australia.
NPJ Parkinson's disease
|June 20, 2025
概括
帕金森病 (PD) 突变会在不同类型的神经元中引起不同的细胞问题. 了解这些帕金森病细胞特异性功能障碍是解释神经元脆弱性和疾病进展的关键.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 帕金森病 (PD) 涉及多种突变 (PRKN,SNCA,LRRK2),导致诸如α-synuclein和tau沉积等多种病理.
- 这些突变与线粒体和 lysosomal 功能障碍有关,但细胞相关性仍然不清楚.
研究的目的:
- 为了比较不同帕金森病突变中的细胞功能障碍.
- 研究PD突变对神经元健康的细胞类型特异性影响.
主要方法:
- 开发了一个公正的高内容成像平台.
- 利用诱导多能干细胞 (iPSC) 衍生的皮层和腹部中脑神经元.
- 评估了溶酶体/线粒体功能障碍,α-synuclein/tau沉积和酶活性.
主要成果:
- 在多巴胺神经元中,PRKN功能丧失突变导致了主要的溶酶体和线粒体功能障碍.
- SNCA和LRRK2突变显示多巴胺神经元中的tau沉积增加.
- 带有SNCA/LRRK2突变的皮层神经元表现出线粒体/自功能障碍,LRRK2也显示出葡萄糖大脑酶活性降低和α-synuclein酸化增加.
结论:
- 不同的帕金森病突变诱导不同的,细胞类型特定的细胞功能障碍.
- 这些细胞特异性功能障碍可能会导致选择性神经元脆弱性和PD病理.
- 这些发现突显了帕金森病中遗传突变,细胞机制和疾病表现之间的复杂相互作用.
相关概念视频
01:22Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
01:15Parkinson's Disease: Overview
722
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
722
01:24Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
01:37Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
01:29Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K